Design and synthesis of novel dual-targeted IRAK4/BTK protein degraders to enhance therapeutic efficacy in aggressive B-cell lymphoma.

Project: Research GrantsResearch

Project Details

AcronymEXODUS-BCL
StatusActive
Effective start/end date1/09/2531/08/28

Funding

  • Agencia Estatal de Investigación: €68,875.00